This expansion will double the current footprint of the facility, bringing it to 120,000+ square feet of compounding, office, and warehouse space. The two new manufacturing areas will allow for the addition of 8 compounding lines.
“This expansion will provide us with the warehouse space we need today, plus the production capacity and facility resources that we will require over the next 5 years. Our current 13 compounding lines will grow to 21 through that period,” said Scott Neal, general manager. “Furthermore, the addition of the cleanroom will allow us to produce the cleanest compounds possible and shows our continued investment in technology in an effort to provide the highest quality compounds to the medical device market.”
Phase one of the expansion was completed in the summer of 2016 with the addition of 4,000 sq. ft. of lab and record retention space. Phase two is the construction of the building expansion and phase three will be the addition of the class 100,000 certified cleanroom.